Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Martin

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Ophthalmology. Retina|January 30, 2026
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional ElementsJustin C Muste, Matthew J Schulgit, Scott Perkins, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Ophthalmology|September 6, 2016
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola SurvivorJessica G Shantha, Ian Crozier, Jay B Varkey, et al.
Ophthalmology. Retina|October 15, 2020
Patient-Reported Complications after Intravitreal Injection and Their Predictive FactorsMichael S Ramos, Lucy T Xu, Srinidhi Singuri, et al.
Nature|May 6, 2021
Projected land ice contributions to twenty-first-century sea level riseTamsin L Edwards, Sophie Nowicki, Ben Marzeion, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Ophthalmology. Retina|January 30, 2026
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional ElementsJustin C Muste, Matthew J Schulgit, Scott Perkins, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Ophthalmology|September 6, 2016
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola SurvivorJessica G Shantha, Ian Crozier, Jay B Varkey, et al.
Ophthalmology. Retina|October 15, 2020
Patient-Reported Complications after Intravitreal Injection and Their Predictive FactorsMichael S Ramos, Lucy T Xu, Srinidhi Singuri, et al.
Nature|May 6, 2021
Projected land ice contributions to twenty-first-century sea level riseTamsin L Edwards, Sophie Nowicki, Ben Marzeion, et al.
Pageof 12